Genomics of Drug Sensitivity in Cancer |
Pyrimethamine
|
Synonyms |
Daraprim, Chloridine
|
Targets |
Dihydrofolate reductase (DHFR)
|
Target pathway |
Other
|
PubCHEM ID |
4993
|
Jsmol |
|
Download molecule |
4993
|
PUBCHEM IUPAC INCHI |
InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)
|
Smiles |
ClC2(=CC=C(C1(=C(N=C(N)N=C1CC)N))C=C2)
|
Cluster number |
150
|
calculated LogS |
-4,909
|
Molecular weight |
248,716
|
calculated LogP |
2,5414
|
H-Acceptors |
4
|
H-Donors |
2
|
Ro5 violations |
0
|
Druglikeness |
-2,0285
|
DrugScore |
8,61088445735209E-02
|
Mutagenic |
high
|
Tumorigenic |
high
|
Reproductive Effective |
high
|
Irritant |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity2 |
1,4471
|
Rat Acute Toxicity |
2,7833
|
Acute Oral Toxicity |
II
|
Caco-2 Permeability |
Caco2+
|
Caco-2 Permeability2 |
1,2598
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
0,6437
|
AMES Toxicity |
Non AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Inhibitor
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Lysosome
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-3,5909
|